Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC
Condition: Metastatic Castration-resistant Prostate Cancer Intervention: Drug: Phase I and Phase II: LAE001/prednisone + afuresertib Sponsor: Laekna Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials